Context Therapeutics Stock Forum

$Talphera (TLPH.US)$ $Reborn Coffee (REBN.US)$ $N2OFF (NITO.US)$ $Collective Mining (CNL.US)$ $Steakholder Foods (STKH.US)$ $Australian Oilseeds Holdings (COOT.US)$ $Context Therapeutics (CNTX.US)$ $Stride (LRN.US)$ $Zapata Computing (ZPTA.US)$ $DBV Technologies (DBVT.US)$ $Canadian GoldCamps Corp (CAMP.CA)$ $Mustang Bio (MBIO.US)$ $Farmmi (FAMI.US)$
📊⚡️📊

$Context Therapeutics (CNTX.US)$ why cant u fly like DRUG?

$Context Therapeutics (CNTX.US)$ delay in market reaction or institutions own a buttload, if doesnt move all day, look for a push after 3:30 or in a few days

$Context Therapeutics (CNTX.US)$
BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody
BioAtla and Context Therapeutics have entered into an exclusive worldwide license agreement for the development and commercialization of BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody. Key points include:
1. Context obtains exclusive rights to BA3362
2. BioAtla to receive $15.0 million in upfront and ...

$Context Therapeutics (CNTX.US)$
Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
Context Therapeutics, a biopharmaceutical company specializing in solid tumor treatments, has acquired CT-95, a potentially first-in-class mesothelin x CD3 bispecific antibody from Link Immunotherapeutics. This acquisition, announced on July 10, 2024, aligns with Context’s strategy to expand its pipeline of T cell engager assets. CT-95 has already received Investigational New Drug (IND) clearance...